These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22275335)

  • 1. Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011.
    Benn P; Borrell A; Cuckle H; Dugoff L; Gross S; Johnson JA; Maymon R; Odibo A; Schielen P; Spencer K; Wright D; Yaron Y
    Prenat Diagn; 2012 Jan; 32(1):1-2. PubMed ID: 22275335
    [No Abstract]   [Full Text] [Related]  

  • 2. Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011.
    Benn P; Borrell A; Crossley J; Cuckle H; Dugoff L; Gross S; Johnson JA; Maymon R; Odibo A; Schielen P; Spencer K; Wright D; Yaron Y;
    Prenat Diagn; 2011 Jun; 31(6):519-22. PubMed ID: 21604286
    [No Abstract]   [Full Text] [Related]  

  • 3. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.
    Benn P; Borell A; Chiu R; Cuckle H; Dugoff L; Faas B; Gross S; Johnson J; Maymon R; Norton M; Odibo A; Schielen P; Spencer K; Huang T; Wright D; Yaron Y
    Prenat Diagn; 2013 Jul; 33(7):622-9. PubMed ID: 23616385
    [No Abstract]   [Full Text] [Related]  

  • 4. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting.
    Ehrich M; Deciu C; Zwiefelhofer T; Tynan JA; Cagasan L; Tim R; Lu V; McCullough R; McCarthy E; Nygren AO; Dean J; Tang L; Hutchison D; Lu T; Wang H; Angkachatchai V; Oeth P; Cantor CR; Bombard A; van den Boom D
    Am J Obstet Gynecol; 2011 Mar; 204(3):205.e1-11. PubMed ID: 21310373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly.
    Benn P; Cuckle H; Pergament E
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):127-30. PubMed ID: 22278776
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies.
    Boon EM; Faas BH
    Prenat Diagn; 2013 Jun; 33(6):563-8. PubMed ID: 23613171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prenatal diagnosis of genetic diseases: Lausanne experience 1989-1993].
    Fokstuen S; Pescia G; Addor MC; Gaide AC; Marguerat P; Maillard C; Vial Y; Hohlfeld P; Nguyen The H
    Rev Med Suisse Romande; 1994 Dec; 114(12):1055-65. PubMed ID: 7817068
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of Down syndrome: the Jerusalem experience.
    Bach G; Ben-Neriah Z; Sagi M
    Isr J Med Sci; 1993 Aug; 29(8):468-70. PubMed ID: 7691779
    [No Abstract]   [Full Text] [Related]  

  • 9. Low MSAFP and new biochemical markers for Down syndrome: implications for genetic counselors.
    Kloza EM
    Birth Defects Orig Artic Ser; 1990; 26(3):31-43. PubMed ID: 1709365
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prenatal diagnosis and screening for Down syndrome. The Danish Society of Medical Genetics].
    Jensen PK
    Ugeskr Laeger; 2004 Mar; 166(12):1115. PubMed ID: 15067774
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethnic differences in participation in prenatal screening for Down syndrome: a register-based study.
    Fransen MP; Schoonen MH; Mackenbach JP; Steegers EA; de Koning HJ; Laudy JA; Galjaard RJ; Looman CW; Essink-Bot ML; Wildschut HI
    Prenat Diagn; 2010 Oct; 30(10):988-94. PubMed ID: 20799374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 13. Maternal serum screening.
    Lofsky S
    CMAJ; 1999 Apr; 160(8):1125-6. PubMed ID: 10234332
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the current dilemma of Down syndrome screening.
    Rose NC
    Obstet Gynecol; 2006 Jan; 107(1):2-3. PubMed ID: 16394031
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possibilities of genetic counseling for prenatal diagnosis in pediatric practice].
    Murken JD; Stengel-Rutkowski S; Zahn V; Jensen M
    Fortschr Med; 1979 Sep; 97(34):1443-7. PubMed ID: 159245
    [No Abstract]   [Full Text] [Related]  

  • 17. Anomalous marker patterns in Down syndrome screening.
    Wald NJ; Bestwick JP; Barnes IM; Kellner LH
    Prenat Diagn; 2007 Feb; 27(2):185-6. PubMed ID: 17266168
    [No Abstract]   [Full Text] [Related]  

  • 18. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
    Wyatt P
    Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete trisomy 21 vs translocation Down syndrome: a comparison of modes of ascertainment.
    Bornstein E; Lenchner E; Donnenfeld A; Jodicke C; Keeler SM; Kapp S; Divon MY
    Am J Obstet Gynecol; 2010 Oct; 203(4):391.e1-5. PubMed ID: 20691415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 46,XY,i(21q) identified by maternal serum screening.
    Meyers CM; Ghori S; Roberson AE; Blitzer MG; Cohen MM
    Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.